Rhode Island is strong in biomedical innovation, advancing scientific knowledge of biological processes and systems in ways that are reshaping the diagnosis and treatment of medical conditions. There are particularly attractive market opportunities in neuroscience-related therapeutics; medical devices for orthopedic, bio-sensing, and neurological applications; and healthcare informatics and digital innovations.
Biomedical innovations are converging with technology development in other scientific fields – including electronics, information technology, imaging, and nanoscience – to offer new insights that inform the creation of biomedical products. Biomedical innovation requires close collaboration between basic research, clinical research, and industry development, all of which is easily facilitated in Rhode Island.
Rhode Island’s health and life sciences industry concentration is 31% higher than the national average.
With CVS Health headquartered in Rhode Island, and new arrivals like Johnson & Johnson coming to the state, the biomedical innovation ecosystem continues to innovate and thrive.
Rhode Island has strong indigenous assets in the following areas- next gen biopharma manufacturing, drug delivery, genetic engineering, immunotherapy, med device design and development and digital health.
Neuroscience is a point of distinction for Rhode Island, with five institutions partnering to collaborate on research – Brown University, University of Rhode Island, Lifespan, Care New England, and the Providence VA Medical Center.